
|Articles|December 1, 2004
Paradigm shift needed in treating severe AD
Boston - Therapeutic strategies for patients with recalcitrant or severe atopic dermatitis (AD) should include a plan to manage acute flares but also maintain disease control over the longer term, said Seth J. Orlow, M.D., Ph.D., at the American College of Allergy, Asthma, & Immunology's Derm Fest here.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















